BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25695279)

  • 1. Expression and mutational analysis of Cip/Kip family in early glottic cancer.
    Kim DK; Lee JH; Lee OJ; Park CH
    J Laryngol Otol; 2015 Feb; 129(2):168-73. PubMed ID: 25695279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
    Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ
    Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of p21(CIP 1), p27(KIP 1) and p 57(KIP 2) methylation in MDS and AML.
    Brakensiek K; Länger F; Kreipe H; Lehmann U
    Leuk Res; 2005 Nov; 29(11):1357-60. PubMed ID: 15936816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the Effect of Zebularine in Comparison to and in Combination with Trichostatin A on p21Cip1/Waf1/ Sdi1, p27Kip1, p57Kip2, DNA Methyltransferases and Histone Deacetylases in Colon Cancer LS 180 Cell Line.
    Sanaei M; Kavoosi F
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1819-1828. PubMed ID: 32592383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of mice without Cip/Kip CDK inhibitors.
    Tateishi Y; Matsumoto A; Kanie T; Hara E; Nakayama K; Nakayama KI
    Biochem Biophys Res Commun; 2012 Oct; 427(2):285-92. PubMed ID: 23000166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer.
    Shin JY; Kim HS; Lee KS; Kim J; Park JB; Won MH; Chae SW; Choi YH; Choi KC; Park YE; Lee JY
    Exp Mol Med; 2000 Jun; 32(2):79-83. PubMed ID: 10926119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer.
    Pateras IS; Apostolopoulou K; Koutsami M; Evangelou K; Tsantoulis P; Liloglou T; Nikolaidis G; Sigala F; Kittas C; Field JK; Kotsinas A; Gorgoulis VG
    Int J Cancer; 2006 Dec; 119(11):2546-56. PubMed ID: 16988944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of cell cycle arrest and terminal differentiation in a maximally proliferative human epithelial tissue: Lessons from the human hair follicle matrix.
    Purba TS; Brunken L; Peake M; Shahmalak A; Chaves A; Poblet E; Ceballos L; Gandarillas A; Paus R
    Eur J Cell Biol; 2017 Sep; 96(6):632-641. PubMed ID: 28413121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
    Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A
    J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.
    Zohny SF; Baothman OA; El-Shinawi M; Al-Malki AL; Zamzami MA; Choudhry H
    Cancer Biomark; 2017; 18(4):413-423. PubMed ID: 28106536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer.
    Pruneri G; Pignataro L; Carboni N; Buffa R; Di Finizio D; Cesana BM; Neri A
    J Clin Oncol; 1999 Oct; 17(10):3150-9. PubMed ID: 10506612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Zebularine in Comparison to and in Combination with Trichostatin A on CIP/KIP Family (p21Cip1/Waf1/Sdi1, p27Kip1, and p57Kip2), DNMTs (DNMT1, DNMT3a, and DNMT3b), Class I HDACs (HDACs 1, 2, 3) and Class II HDACs (HDACs 4, 5, 6) Gene Expression, Cell Growth Inhibition and Apoptosis Induction in Colon Cancer LS 174T Cell Line.
    Sanaei M; Kavoosi F
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2131-2139. PubMed ID: 32711442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells.
    Shin JY; Kim HS; Park J; Park JB; Lee JY
    Cancer Res; 2000 Jan; 60(2):262-5. PubMed ID: 10667572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular Response upon Stress: p57 Contribution to the Final Outcome.
    Rossi MN; Antonangeli F
    Mediators Inflamm; 2015; 2015():259325. PubMed ID: 26491224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of G1 cell-cycle inhibitors in early laryngeal cancer.
    Korkmaz H; Du W; Yoo GH; Enamorado II; Lin HS; Adsay V; Kewson D; Ensley JF; Shibuya TY; Jacobs JR; Kim H
    Am J Otolaryngol; 2005; 26(2):77-82. PubMed ID: 15742257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic localization of p21 protects trophoblast giant cells from DNA damage induced apoptosis.
    de Renty C; DePamphilis ML; Ullah Z
    PLoS One; 2014; 9(5):e97434. PubMed ID: 24848107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p57KIP2: "Kip"ing the cell under control.
    Pateras IS; Apostolopoulou K; Niforou K; Kotsinas A; Gorgoulis VG
    Mol Cancer Res; 2009 Dec; 7(12):1902-19. PubMed ID: 19934273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients.
    Chim CS; Fung TK; Wong KF; Lau JS; Law M; Liang R
    J Clin Pathol; 2006 Sep; 59(9):921-6. PubMed ID: 16565223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of cyclin dependent kinase inhibitors of KIP family in gastric cancer].
    Lee SJ; Joo YE; Kim HS; Choi SK; Rew JS; Park CS; Kim SJ
    Korean J Gastroenterol; 2005 Aug; 46(2):84-93. PubMed ID: 16118517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.